Does CANAKINUMAB Cause Nasopharyngitis? 238 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 238 reports of Nasopharyngitis have been filed in association with CANAKINUMAB (Ilaris). This represents 2.3% of all adverse event reports for CANAKINUMAB.
238
Reports of Nasopharyngitis with CANAKINUMAB
2.3%
of all CANAKINUMAB reports
5
Deaths
55
Hospitalizations
How Dangerous Is Nasopharyngitis From CANAKINUMAB?
Of the 238 reports, 5 (2.1%) resulted in death, 55 (23.1%) required hospitalization, and 7 (2.9%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for CANAKINUMAB.
What Other Side Effects Does CANAKINUMAB Cause?
Pyrexia (1,327)
Inappropriate schedule of drug administration (1,238)
Drug ineffective (1,078)
Inappropriate schedule of product administration (944)
Pain (858)
Condition aggravated (771)
Malaise (684)
Off label use (557)
Arthralgia (555)
Rash (505)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which CANAKINUMAB Alternatives Have Lower Nasopharyngitis Risk?
CANAKINUMAB vs CANDESARTAN
CANAKINUMAB vs CANDESARTAN CILEXETIL
CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANAKINUMAB vs CANGRELOR
CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN